Description
Drug Delivery Trends examines a drift in the pharmaceutical field across the wide range of dosage forms, drug delivery systems (micro and nanoparticulate), at the regulatory front and on new types of therapies in the market. This volume additionally covers the challenges on drug delivery systems in terms of preclinical and current ways of determining quality and the options to solve the challenges associated with this. Most small-medium scale industries and academics struggle with initial regulatory challenges so a detailed discussion on regulatory trend covers the necessary basic understanding of regulatory procedures and provides the required guidance.The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers.Expectations and Realities of Multifunctional Drug Delivery Systems connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stake holders. The wide scope of the book ensures it as a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about drug delivery systems.- Encompasses trends in drug delivery systems and selected dosage forms- Illustrates regulatory, preclinical and quality principles- Contains in-depth investigation of upcoming types of drug delivery systems
Table of Contents
1. Bioactive hybrid nanowires: a new in trend for site-specific drug delivery and targeting A.R. FERNANDES, J. DIAS-FERREIRA, M.C. TEIXEIRA, A.A.M. SHIMOJO, PATRÍCIA SEVERINO, A.M. SILVA, RANJITA SHEGOKAR, AND ELIANA B. SOUTO2. Opportunities and challenges of 3D-printed pharmaceutical dosage forms ADAM PROCOPIO AND DIVYA TEWARI3. Marketing authorization and licensing of medicinal products in EU: Regulatory aspects MUHANED AL-HINDAWI4. Clinical considerations on micro- and nanodrug delivery systems PRAMIL TIWARI, VIVEK RANJAN SINHA, AND RANDEEP KAUR5. Nanoparticulate treatments for oral delivery ROHIT C. GHAN6. Pharmaceutical mini-tablets: a revived trend VENKAT TUMULURI7. Liquid crystalline drug delivery systems LUCIANA NALONE, CONRADO MARQUES, SALVANA COSTA, ELIANA B. SOUTO, AND PATRÍCIA SEVERINO8. Amorphous drug stabilization using mesoporous materials DANILLO F.M.C. VELOSO, MATTHIAS M. KNOPP, AND KORBINIAN L€OBMANN9. "Quality of pharmaceutical products for human usedunderlying concepts and required practices SAEED A. QURESHI10. Optimizing intraperitoneal drug delivery: pressurized intraperitoneal aerosol chemotherapy (PIPAC) M.A. REYMOND AND A. K€ONIGSRAINER11. Upscaling and GMP production of pharmaceutical drug delivery systems NAZENDE G€UNDAY T€URELI AND AKIF EMRE T€URELI
